Hermetica Superfood Encyclopedia
Legacy index-continuity record: the score and narrative are provisional and must not be represented as validated or human-approved.
Review flags: AWAITING_SEMANTIC_VALIDATION
Coumestrol is a naturally occurring coumestan phytoestrogen found in legumes such as alfalfa, clover, and soybeans. It exerts its primary effects by competitively binding to estrogen receptors ERα and ERβ, with binding affinities of 94% and 185% relative to estradiol, respectively, making it one of the most potent known dietary phytoestrogens.
Origin & History
Coumestrol is a naturally occurring phytoestrogen belonging to the coumestan class of flavonoids, with highest concentrations found in red clover (1.3 g/100g), alfalfa sprouts (1.60 mg/100g), and raw clover sprouts (14.08 mg/100g). It is extracted from legumes and plant sprouts using solvent-based methods, with its low molecular weight (268.22 Da) enabling ready absorption across cell membranes.
Research Narrative (Provisional)
The research dossier explicitly states that comprehensive human randomized controlled trials are not detailed in the provided sources and no PubMed PMIDs are included. The available evidence consists primarily of in vitro receptor binding studies showing coumestrol binds ERα with IC₅₀ = 11 nM, and animal toxicity studies used to calculate maximum tolerable daily intake of 22 µg/kg body weight.
Preparation & Dosage
Dosage guidance is withheld because the publication gate has not recorded adequate support for this profile.
Nutritional Profile
Coumestrol is a pure phytoestrogenic coumestan compound (molecular formula C15H8O5, molecular weight 268.22 g/mol), not a whole food ingredient, therefore it has no macronutrient, vitamin, mineral, or fiber content in isolation. Bioactive composition is 100% coumestrol as the sole active entity when in isolated form. In natural food sources, coumestrol occurs at measurable concentrations: sprouted alfalfa seeds (up to 0.14–1.0 mg/g dry weight), split peas (0.2–2.0 µg/g fresh weight), pinto beans (~0.2 µg/g), spinach (~0.17 µg/g), and Brussels sprouts (trace amounts ~0.02 µg/g). As a polyphenolic coumestan, it contains no caloric value in physiologically relevant doses. Bioavailability notes: oral bioavailability is moderate; coumestrol undergoes intestinal absorption with peak plasma concentrations reached within 1–3 hours post-ingestion. It is subject to phase II hepatic metabolism (glucuronidation and sulfation), enterohepatic recirculation has been documented, and gut microbiota composition significantly influences bioavailability. Protein-bound fraction in plasma is high (>95%, primarily albumin-bound). No dietary reference intake or established tolerable upper limit has been defined by regulatory bodies. Estrogenic potency is estimated at approximately 0.1–0.2% that of 17β-estradiol in vivo, despite high in vitro receptor binding affinity.
Reported Mechanism (Provisional)
Coumestrol binds competitively to estrogen receptors ERα and ERβ, with relative binding affinities of approximately 94% and 185% compared to 17β-estradiol, allowing it to function as both an estrogen agonist and partial antagonist depending on tissue context and endogenous estrogen levels. Once bound, the coumestrol-receptor complex translocates to the nucleus and modulates estrogen response element (ERE)-driven gene transcription, influencing genes involved in cell proliferation, bone metabolism, and lipid regulation. Coumestrol also inhibits aromatase (CYP19A1) activity in vitro, potentially modulating local estrogen biosynthesis in hormone-sensitive tissues.
Clinical Narrative (Provisional)
The majority of evidence supporting coumestrol's biological activity comes from in vitro cell studies and animal models, with very limited dedicated human clinical trials. Rodent studies have demonstrated effects on uterine tissue, bone density preservation, and reproductive hormone profiles at doses not directly translatable to human supplementation. Epidemiological observations of populations consuming high-legume diets suggest associations with altered menopausal symptom profiles, but coumestrol is rarely isolated as the sole variable. No large-scale, placebo-controlled human RCTs have established efficacious or safe supplemental doses of isolated coumestrol, making evidence strength low to preliminary overall.
Also Known As
Research updates — and 25% off your first order
Join our list for source-aware wellness education, review-state updates, and product news — and unlock 25% off your first Hermetica order. Educational content is not medical advice. No spam, unsubscribe anytime.